Gritstone bio, Inc. Profile Avatar - Palmy Investing

Gritstone bio, Inc.

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid t…

Biotechnology
US, EmeryVille [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Gritstone bio, Inc. (GRTS) to it's peer group.

Peer Group
Loading...
End of GRTS's Analysis
CIK: 1656634 CUSIP: 39868T105 ISIN: US39868T1051 LEI: - UEI: -
Secondary Listings
GRTS has no secondary listings inside our databases.